Clinical Trial Update: Biomarkers of Neurodegeneration and Neuroplasticity in Parkinson's Disease Patients Treated by Bilateral M1-iTBS [NA]

View source ↗

Summary

A completed Parkinson's disease trial evaluated biomarkers of neurodegeneration and neuroplasticity in patients treated with bilateral M1-iTBS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• bilateral M1-iTBS (intermittent theta-burst stimulation targeting primary motor cortex)

Snippet

Sponsor: Instituto de investigación e innovación biomédica de Cádiz | Conditions: Parkinson's Disease | NA | Status: COMPLETED